Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday.
After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures.
“It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent company Adimmune Corp (國光生技) told the Taipei Times yesterday.
Photo courtesy of Adimmune Corp
“However, we are working with the government, and hope that this vaccine could be included in a national vaccination program for children, as EV-71 is a common pathogen that causes polio-like syndrome and can lead to severe sickness,” Adimmune said.
As the vaccine would be administered to children younger than five and each child would need to have two shots, the total demand for the vaccine in Taiwan is estimated at 300,000 doses per year, the company said.
EnVAX-A71 is designed to act against genotype B4 of EV-71, which is widespread in Taiwan.
Enimmune has signed a memorandum of understanding with a Vietnamese state-run vaccine company to collaborate on EnVAX-A71 and is to complete a phase-three human test of the vaccine in the country in the near term.
In the long term, the company aims to enter the Southeast Asian market where demand for an enterovirus vaccine could exceed 20 million doses, it said, adding that it also plans to enter the Chinese market.
Enimmune’s revenue grew 72 percent year-on-year to NT$188 million last year, while Adimmune’s revenue grew 37 percent to NT$2.25 billion, companies data showed.
Local rival Medigen Vaccine Biologics Corp (高端疫苗) is also developing an enterovirus vaccine in Taiwan, but has not yet obtained marketing approval after submitting an application in 2021.
RUN IT BACK: A succesful first project working with hyperscalers to design chips encouraged MediaTek to start a second project, aiming to hit stride in 2028 MediaTek Inc (聯發科), the world’s biggest smartphone chip supplier, yesterday said it is engaging a second hyperscaler to help design artificial intelligence (AI) accelerators used in data centers following a similar project expected to generate revenue streams soon. The first AI accelerator project is to bring in US$1 billion revenue next year and several billion US dollars more in 2027, MediaTek chief executive officer Rick Tsai (蔡力行) told a virtual investor conference yesterday. The second AI accelerator project is expected to contribute to revenue beginning in 2028, Tsai said. MediaTek yesterday raised its revenue forecast for the global AI accelerator used
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has secured three construction permits for its plan to build a state-of-the-art A14 wafer fab in Taichung, and is likely to start construction soon, the Central Taiwan Science Park Bureau said yesterday. Speaking with CNA, Wang Chun-chieh (王俊傑), deputy director general of the science park bureau, said the world’s largest contract chipmaker has received three construction permits — one to build a fab to roll out sophisticated chips, another to build a central utility plant to provide water and electricity for the facility and the other to build three office buildings. With the three permits, TSMC
The DBS Foundation yesterday announced the launch of two flagship programs, “Silver Motion” and “Happier Caregiver, Healthier Seniors,” in partnership with CCILU Ltd, Hondao Senior Citizens’ Welfare Foundation and the Garden of Hope Foundation to help Taiwan face the challenges of a rapidly aging population. The foundation said it would invest S$4.91 million (US$3.8 million) over three years to foster inclusion and resilience in an aging society. “Aging may bring challenges, but it also brings opportunities. With many Asian markets rapidly becoming super-aged, the DBS Foundation is working with a regional ecosystem of like-minded partners across the private, public and people sectors
BREAKTHROUGH TECH: Powertech expects its fan-out PLP system to become mainstream, saying it can offer three-times greater production throughput Chip packaging service provider Powertech Technology Inc (力成科技) plans to more than double its capital expenditures next year to more than NT$40 billion (US$1.31 billion) as demand for its new panel-level packaging (PLP) technology, primarily used in chips for artificial intelligence (AI) applications, has greatly exceeded what it can supply. A significant portion of the budget, about US$1 billion, would be earmarked for fan-out PLP technology, Powertech told investors yesterday. Its heavy investment in fan-out PLP technology over the past 10 years is expected to bear fruit in 2027 after the technology enters volume production, it said, adding that the tech would
RSS